| Primary |
| Staphylococcal Infection |
13.3% |
| Sepsis |
12.5% |
| Infection |
9.5% |
| Pneumonia |
8.4% |
| Lung Abscess |
6.1% |
| Staphylococcal Sepsis |
6.1% |
| Tuberculosis |
5.7% |
| Endocarditis |
4.6% |
| Device Related Infection |
4.2% |
| Urinary Tract Infection |
3.8% |
| Febrile Neutropenia |
3.0% |
| Lung Disorder |
3.0% |
| Osteomyelitis |
3.0% |
| Pneumonia Staphylococcal |
3.0% |
| Chemotherapy |
2.7% |
| Hiv Infection |
2.3% |
| Infected Skin Ulcer |
2.3% |
| Nocardiosis |
2.3% |
| Prophylaxis |
2.3% |
| Analgesic Therapy |
1.9% |
|
| Thrombocytopenia |
26.7% |
| Renal Failure Acute |
7.8% |
| Hepatitis Acute |
5.2% |
| Hepatitis Cholestatic |
4.3% |
| Leukopenia |
4.3% |
| Serotonin Syndrome |
4.3% |
| Toxic Encephalopathy |
4.3% |
| Transaminases Increased |
4.3% |
| Tremor |
4.3% |
| Vomiting |
4.3% |
| Acute Generalised Exanthematous Pustulosis |
3.4% |
| Hepatitis |
3.4% |
| Jaundice |
3.4% |
| Pancytopenia |
3.4% |
| Pharyngeal Oedema |
3.4% |
| Agranulocytosis |
2.6% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.6% |
| Lactic Acidosis |
2.6% |
| Neuropathy Peripheral |
2.6% |
| Nocardiosis |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.2% |
| Product Used For Unknown Indication |
23.0% |
| Pneumonia Necrotising |
6.5% |
| Tuberculosis |
6.5% |
| Lung Disorder |
5.9% |
| Staphylococcal Infection |
5.4% |
| Infection |
4.8% |
| Lung Abscess |
3.1% |
| Antibiotic Therapy |
2.2% |
| Sepsis |
2.2% |
| Chemotherapy |
2.0% |
| Pneumonia |
2.0% |
| Pain |
1.7% |
| Pulmonary Tuberculosis |
1.7% |
| Hypertension |
1.5% |
| Tracheobronchitis |
1.5% |
| Antibiotic Prophylaxis |
1.2% |
| Endocarditis |
1.2% |
| Osteitis |
1.2% |
| Respiratory Tract Infection |
1.2% |
|
| Thrombocytopenia |
21.0% |
| Ventricular Extrasystoles |
9.5% |
| Polyneuropathy |
8.6% |
| Vomiting |
5.7% |
| Jaundice Cholestatic |
4.8% |
| Pneumonia |
4.8% |
| Renal Failure Acute |
4.8% |
| Acquired Haemophilia |
3.8% |
| Lactic Acidosis |
3.8% |
| Rash Maculo-papular |
3.8% |
| Septic Shock |
3.8% |
| Cytolytic Hepatitis |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.9% |
| Hepatitis |
2.9% |
| Hepatitis Cholestatic |
2.9% |
| Nausea |
2.9% |
| Pancytopenia |
2.9% |
| Rash |
2.9% |
| Shock |
2.9% |
| Thrombophlebitis Superficial |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.2% |
| Drug Use For Unknown Indication |
19.4% |
| Prophylaxis |
5.9% |
| Staphylococcal Infection |
4.9% |
| Antibiotic Therapy |
3.6% |
| Enterococcal Infection |
3.6% |
| Hiv Infection |
3.4% |
| Escherichia Infection |
3.0% |
| Respiratory Tract Infection Bacterial |
2.8% |
| Pain |
2.7% |
| Pneumonia |
2.7% |
| Tuberculosis |
2.7% |
| Prophylaxis Against Transplant Rejection |
2.3% |
| Depression |
2.1% |
| Lung Disorder |
2.1% |
| Unevaluable Event |
2.1% |
| Acute Myeloid Leukemia |
1.9% |
| Infection |
1.9% |
| Klebsiella Infection |
1.9% |
| Respiratory Tract Infection |
1.9% |
|
| Toxic Skin Eruption |
14.1% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
9.0% |
| Respiratory Failure |
7.7% |
| Transaminases Increased |
6.4% |
| Rash |
5.1% |
| Rhabdomyolysis |
5.1% |
| Sepsis |
5.1% |
| Thrombocytopenia |
5.1% |
| Weight Decreased |
5.1% |
| Death |
3.8% |
| Haemorrhage Intracranial |
3.8% |
| Hepatocellular Injury |
3.8% |
| Pigmentation Disorder |
3.8% |
| Toxic Epidermal Necrolysis |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Weight Increased |
3.8% |
| Coma |
2.6% |
| Cytolytic Hepatitis |
2.6% |
| Liver Abscess |
2.6% |
| Liver Disorder |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
16.0% |
| Renal Transplant |
12.0% |
| Atrial Fibrillation |
8.0% |
| Pneumonia |
6.0% |
| Analgesia |
4.0% |
| Analgesic Therapy |
4.0% |
| Enterococcal Bacteremia |
4.0% |
| Hypertension |
4.0% |
| Hypothyroidism |
4.0% |
| Hypoventilation |
4.0% |
| Osteoporosis |
4.0% |
| Pleural Infection |
4.0% |
| Postoperative Analgesia |
4.0% |
| Prophylaxis |
4.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.0% |
| Prophylaxis Urinary Tract Infection |
4.0% |
| Staphylococcal Infection |
4.0% |
| Depression |
2.0% |
| Erysipelas |
2.0% |
| Meningitis Enterococcal |
2.0% |
|
| Leukopenia |
22.2% |
| Serotonin Syndrome |
22.2% |
| Tonic Clonic Movements |
22.2% |
| Neutropenia |
11.1% |
| Overdose |
11.1% |
| Thrombocytopenia |
11.1% |
|
